Fundraising Fox
Blue Ledge Capital
Venture capitalSeed–Series A · 1 people tracked
Find your way into Blue Ledge Capital
Sign up to see every warm intro you have to Blue Ledge Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Blue Ledge Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Blue Ledge Capital invests in businesses building the future, particularly focusing on advanced technology and deep science-based opportunities where others see confusion. The firm partners with institutional backing to enable a sustainable model without asset accumulation pressures, allowing for patient capital deployment alongside rigorous diligence and long-term portfolio support.
Source: firm website, verified Sep 26, 2026.
Team · 1 people
from public directories
What they invest in
from 5 of 8 portfolio companiesBiotech ×3Digital Health ×2Healthtech ×2New Materials ×2AI & Machine Learning ×1Climate Tech ×1Deep Tech ×1FoodTech ×1
HQs:United States×4
Investments · 8 tracked
founders shown can be your intro pathBy year:2023 · 12018 · 12 dated
The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities.
Digital HealthHealthtechImpact & Social Good
Co-investorsBrightEdgeFred Hutchinson Cancer Research Center
Grolltex manufactures single-layer graphene and graphene-based products using patented CVD and transfer technologies, serving customers in life sciences, biotech, sensing, and electronics.
BiotechDeep TechHardwareNew MaterialsSan Diego, US
Aliaksandr Victorovich Zaretski(Founder)in
Co-investorsKeshif VenturesVertical Venture PartnersTech Coast Angels
AvantGuard develops Avantamine, an antimicrobial molecule that eliminates bacteria, viruses, and fungi on surfaces and skin without generating resistance, with an initial focus on topical treatment of the drug-resistant fungal pathogen Candida auris.
BiotechHealthtechNew Materials
Co-investorsRed Bear AngelsSOSV
Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.
Climate TechFoodTechBerkeley, US
Ilan Eitan Fischer(Executive Officer, Director)Eitan Fischer(Founder)
BoardDavid Bowman(Founder)
Co-investorsAir Street CapitalBabel VenturesBetter Ventures Central LlcBloom8GaingelsJoyance Partners+9 more
.png)
__Twitter.png)
Qnovia develops a portable, pre-filled vibrating mesh nebulizer (RespiRx) that delivers nicotine via ultrasonic nebulization without combustion, paired with a cloud-connected AI platform (Neblit) providing real-time behavioral support for smoking cessation.
AI & Machine LearningBiotechDigital HealthMedical DevicesRichmond, US
Mario Danek(Founder)inBrian Quigley(Executive Officer, Director)
BoardSean Fahey(Director)Brian Riano(Director)Gregg Smith(Director)in
Co-investorsEvolution VC PartnersGaingelsSand Hill AngelsVice Ventures
Developer of an inhalation device and liquid formulation to deliver inhalable nicotine without harmful constituents, pursuing FDA 505(b)(2) authorization for the first inhalable Nicotine Replacement Therapy; BlueLedge led its bridge rounds ahead of its 2020/2021 Series A.
Co-investorsEvolution VC PartnersSand Hill Angels
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ExogenesisnanoMesh
Frequently asked questions
- How many investments has Blue Ledge Capital made?
- Blue Ledge Capital has 8 tracked investments.
- What stage does Blue Ledge Capital invest at?
- Blue Ledge Capital invests at the Seed, Series A stages.
- What sectors does Blue Ledge Capital focus on?
- Blue Ledge Capital focuses on Biotech, Deep Tech, FoodTech, Medical Devices, New Materials.
- Does Blue Ledge Capital lead rounds?
- Yes, Blue Ledge Capital leads investment rounds.
- Who does Blue Ledge Capital co-invest with?
- Blue Ledge Capital most often shares deals with Better Ventures Central Llc, Gaingels, Keshif Ventures, among 16 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Mission BioCapital provides early-stage capital and shared lab space to life science entrepreneurs, supporting companies from idea through clinic and exit.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.